Resveratrol induces autophagy by activating sirt1, improving the oxLDL uptake and enhancing efferocytosis of apoptotic RAW264.7 cells [95], suggesting that sirt1 could be used as a novel therapeutic target for atherosclerosis treatment [95]. This evidence concerns the gene SIRT1 and atherosclerosis.